Christine Borowski - 01 Jan 2024 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VYNE	Stock Option (right to buy)	Award	$0	+40,000		$0.000000	40,000	01 Jan 2024	Common Stock	40,000	$2.33	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The option will vest and become exercisable as to 1/3rd of the shares subject to the option on each annual anniversary of the date of grant, subject to the Reporting Person's continuous service through each applicable vesting date.